Akcije

Archive of Oncology
kako citirati ovaj članak
podeli ovaj članak

Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:7
  • preuzimanja u poslednjih 30 dana:3

Sadržaj

članak: 1 od 2  
Back povratak na rezultate
2017, vol. 23, br. 2, str. 17-19
Analysis of SMAD4 gene promoter methylation in pancreatic and endometrial cancers
(naslov ne postoji na srpskom)
aUniverzitet u Beogradu, Institut za molekularnu genetiku i genetičko inženjerstvo
bUniverzitet u Beogradu, Medicinski fakultet, Institut za biologiju i humanu genetiku
cKlinički centar Srbije, Klinika za digestivnu hirurgiju – I hirurška, Beograd

e-adresaaleksni@imgge.bg.ac.rs
Projekat:
Kompleksne bolesti kao model sistem za proučavanje modulacije fenotipa-strukturna i funkcionalna analiza molekularnih biomarkera (MPNTR - 173008)

Sažetak
(ne postoji na srpskom)
Background. Promoter hypermethylation of the SMAD4 gene has been registered in some cancer types, but in general doesn't appear to be a frequent event in carcinogenesis. However, only a few published studies deal with this topic and not many cancer types have been analyzed. The aim of this study was to establish SMAD4 gene promoter methylation status in pancreatic and endometrial cancers. Methods. Patients included in the study (62 subjects) were diagnosed and surgically treated at the University of Belgrade, Clinical Center of Serbia. Patients with pancreatic carcinoma (17 subjects) underwent surgical removal of the pancreatic adenocarcinoma at the First Surgical Clinic, while the patients with endometrial carcinoma (45 subjects) underwent hysterectomy with adnexectomy at the Institute for Gynecology and Obstetrics. Extraction of DNA from fresh tissue samples was performed and the methylation status of the SMAD4 gene promoter was studied by a previously designed PCR-based HpaII and MspI restriction enzyme assay. The resulting PCR products were analyzed by electrophoresis in 2% agarose gels. Results. Neither of the analyzed samples was found to be hypermethylated. Conclusion. This is the first report on SMAD4 methylation status in pancreatic and endometrial tumor specimens, and supports the viewpoint that SMAD4 hypermethylation is not a common event in malignant tumors. Nevertheless, promoter hypermethylation remains a candidate mechanism for SMAD4 inactivation in malignant tissue as a potential cause of decreased or lost SMAD4 expression in certain tumor types, and should be further investigated in different tumor types and larger cohorts of patients.
Reference
Aitchison, A.A., Veerakumarasivam, A., Vias, M., Kumar, R., Hamdy, F.C., Neal, D.E., Mills, I.G. (2008) Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer. Prostate, 68(6): 661-674
Calva, D., Dahdaleh, F.S., Woodfield, G., Weigel, R.J., Carr, J.C., Chinnathambi, S., Howe, J.R. (2011) Discovery of SMAD4 promoters, transcription factor binding sites and deletions in juvenile polyposis patients. Nucleic Acids Research, 39(13): 5369-5378
Edge, S.B., Compton, C.C. (2010) The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Annals of Surgical Oncology, 17(6): 1471-1474
Fotouhi, O., Adel, F.M., Kjellman, M., Sulaiman, L., Höög, A., Zedenius, J., Hashemi, J., Larsson, C. (2014) Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors. Epigenetics, 9(7): 987-997
Hahn, S.A., Schutte, M., Hoque, A.T., Moskaluk, C.A., da Costa, L.T., Rozenblum, E., Weinstein, C.L., Fischer, A., Yeo, C.J., Hruban, R.H., Kern, S.E. (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science, 271(5247): 350-3
Herceg, Z., Hainaut, P. (2007) Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis. Molecular Oncology, 1(1): 26-41
Miyaki, M., Kuroki, T. (2003) Role of Smad4 (DPC4) inactivation in human cancer. Biochemical and Biophysical Research Communications, 306(4): 799-804
Nikolic, A., Ristanovic, M., Perovic, V., Trifunovic, J., Perovic, M., Radojkovic, D. (2012) Genetic Alterations in SMAD4 and K-ras in Serbian Patients With Endometrial Carcinoma. International Journal of Gynecological Cancer, 22(3): 442-446
Nikolic, A., Kojic, S., Knezevic, S., Krivokapic, Z., Ristanovic, M., Radojkovic, D. (2011) Structural and functional analysis of SMAD4 gene promoter in malignant pancreatic and colorectal tissues: Detection of two novel polymorphic nucleotide repeats. Cancer Epidemiology, 35(3): 265-271
Nikolic, A., Cacev, T., Aralica, G., Hadzija, M.P., Kapitanovic, S., Radojkovic, D. (2015) Mononucleotide repeats in the SMAD4 gene promoter in colon carcinoma tissue of Croatian patients. Experimental and Molecular Pathology, 98(2): 133-135
Onwuegbusi, B.A. (2006) Impaired transforming growth factor   signalling in Barrett's carcinogenesis due to frequent SMAD4 inactivation. Gut, 55(6): 764-774
Roth, S., Laiho, P., Salovaara, R., Launonen, V., Aaltonen, L.A. (2000) No SMAD4 hypermethylation in colorectal cancer. British Journal of Cancer, 83(8): 1015-1019
Sameer, A., Siddiqi, M. (2011) SMAD4 promoter hypermethylation in Kashmiri colorectal cancer cases. Saudi Journal of Gastroenterology, 17(4): 297
Schutte, M. (1999) DPC4/SMAD4 gene alterations in human cancer, and their functional implications. Annals of Oncology, 10(suppl 4): S56-S59
Takenaka, K., Gemma, A., Yoshimura, A., Hosoya, Y., Nara, M., Hosomi, Y., i dr. (2009) Reduced transcription of the Smad4 gene during pulmonary carcinogenesis in idiopathic pulmonary fibrosis. Mol Med Rep, 2: 73-80
Wang, L.-H., Kim, S.-H., Lee, J. H., Choi, Y.-L., Kim, Y. C., Park, T. S., Hong, Y.-C., Wu, C.-F., Shin, Y. K. (2007) Inactivation of SMAD4 Tumor Suppressor Gene During Gastric Carcinoma Progression. Clinical Cancer Research, 13(1): 102-110
Yang, G., Yang, X. (2010) Smad4-mediated TGF-β signaling in tumorigenesis. International Journal of Biological Sciences, str. 1-8
Zhou, Y., Kato, H., Shan, D., Minami, R., Kitazawa, S., Matsuda, T., Arima, T., Barrett, J. C., Wake, N. (1999) Involvement of mutations in theDPC4 promoter in endometrial carcinoma development. Molecular Carcinogenesis, 25(1): 64-72
 

O članku

jezik rada: engleski
vrsta rada: izvorni naučni članak
DOI: 10.2298/AOO1702017N
objavljen u SCIndeksu: 01.03.2018.
metod recenzije: jednostruko anoniman
Creative Commons License 4.0

Povezani članci

Nema povezanih članaka